论文部分内容阅读
血清铁蛋白检测方法不断进展。各种肿瘤患者血清中显示铁蛋白含量增高,但其增高的临床意义与机制尚未阐明。作者采用可逆性被动血球凝集试验(PHA)法测定血清铁蛋白。病例为可手术切除癌症患者22例,不能根治的晚期癌症患者121例、正常人27例及非癌症患者108例。癌症病例以无感染、胶原性疾病及其它合并症者作为选择条件。结果①正常人血清铁蛋白的平均值为222ng/ml,女性稍低,与年龄之间未发现相关。②非癌症病例的血清铁蛋白值一般很少显示高值,但胆囊
Serum ferritin detection methods continue to advance. Serum levels of ferritin have been shown to increase in patients with various tumors, but their clinical significance and mechanisms have not yet been elucidated. The authors used the reversible passive hemagglutination test (PHA) method to measure serum ferritin. The cases were surgically resected cancer patients in 22 cases, 121 patients with advanced cancer that could not be cured, 27 normal subjects and 108 non-cancer patients. Cases of cancer were selected with no infection, collagen diseases, and other complications. Results 1 The average serum ferritin level in normal subjects was 222 ng/ml, which was slightly lower in women. No correlation was found between age and age. 2 Serum ferritin values in non-cancer cases are seldom shown to be high, but gallbladder